Advanced Oncotherapy (AVO) – Additional financing agreement

Advanced Oncotherapy plc (AIM: AVO), the developer of next generation proton therapy systems for cancer treatment, announces that on Tuesday 25 April it drew down a further £2 million as part of the 12-month convertible and redeemable loan agreement announced on 27 March 2017 with Blackfinch Investment Ltd, through its subsidiary Henslow Trading Limited. This […]

Sabien Technology (SNT) – Pilot Programme showing promise

Sabien Technology (SNT) – Pilot Programme showing promise. A broker note from Stockdale Securities.   The key elements of the interims in our view are that 30 UK pilots have been agreed for this heating season and that the sales pipeline has increased to £6.4m from the last-reported £5.8m. As anticipated the adj. LBT increased […]

Advanced Oncotherapy – Change of name of NOMAD & Joint Broker

Change of name of Nominated Adviser and Joint Broker   The Company notifies that its Nominated Adviser and Joint Broker has changed its registered name from Westhouse Securities Limited to Stockdale Securities Limited. Advanced Oncotherapy Plc www.avoplc.com Sanjeev Pandya, CEO Tel: +44 20 3617 8728 Nicolas Serandour, CFO Stockdale Securities (Nomad & Joint Broker) Antonio […]